FdaApplication
ANDA 214512
Identifiers
- fda_app_no: ANDA214512
Properties
| Property | Value |
|---|---|
| applicant_name | NOVITIUM PHARMA LLC |
| application_type | ANDA |
| approval_date | 2023-05-11 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ALENDRONATE SODIUM | ALENDRONATE SODIUM | EQ 70MG BASE/75ML | SOLUTION;ORAL |
1 product